Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Mar 7 2019


Images knee.jpg
  • Snapshot
    • A 70-year-old man presents to the emergency department for severe left knee pain. Medical history is significant for hyperparathyroidism managed with bisphosphonates. On physical exam, the left knee is erythematous, warm, enlarged, and tender to palpation. Radiography of the affected joint demonstrates chondrocalcinosis. Joint aspiration demonstrates a leukocyte count of 2800/mm3 with 50% polymorphonuclear cells. Polarized microscopy shows weakly positively birefringent rhomboid crystals.
  • Introduction
    • Clinical definition
      • a metabolic arthropathy due to deposition of calcium pyrophosphate dihydrate (CPP) in connective tissue
    • Epidemiology
      • risk factors
        • radiographic CPP deposition increases with age
    • Etiology
      • CPP deposition in joints
    • Pathogenesis
      • aging and/or genetic factors may result in increased adenosine triphosphate breakdown producing inorganic pyrophosphate
        • CPP is produced after inorganic pyrophosphate binds with calcium
          • CPP then deposits in cartilage and synovial fluid leading to a synovitis
    • Associated conditions
      • hemochromatosis
      • hyperparathyroidism
      • hypomagnesemia
        • can be seen in Gitelman and Bartter syndrome
      • joint trauma, surgery, and severe medical illness
        • these conditions can provoke an acute attack
    • Prognosis
      • acute attacks typically resolve in 10 days
      • patients may experience functional limitation due to joint damage
      • may resemble osteoarthritis or rheumatoid arthritis
  • Presentation
    • Symptoms
      • asymptomatic (most cases)
      • acute attack (pseudogout)
        • typically affects the wrists, knees, and metacarpophalangeal joints
        • are clinically indistinguishable from gout
        • symptoms and physical exam findings include
          • pain
          • erythema
          • warmth
          • swelling
          • disability of the affected joint
      • "pseudo-rheumatoid arthritis"
        • inflammatory arthritis symptoms
          • joint pain and morning stiffness
      • pyrophosphate arthropathy
        • resembles osteoarthritis
  • Imaging
    • Radiography
      • indication
        • to assess the affected joint
      • findings
        • chondrocalcinosis and degenerative changes
          • chondrocalcinosis appears as hyperdensities that are punctate and linear
  • Studies
    • Arthrocentesis
      • confirms the diagnosis
      • Gram stain and culture should always be performed since infection could co-exist
      • leukocyte count is 2,000-100,000/mm3
        • > 50% polymorphonuclear cells
      • polarized microscopy demonstrates weakly positively birefringent rhomboid crystals
        • blue when parallel to light and yellow when perpendicular to light
  • Differential
    • Gout
      • differentiating factor
        • polarized microscopy demonstrates negatively birefringent crystals
        • more commonly affects the first metatarsophalangeal (MTP) joint
  • Treatment
    • Conservative
      • observation
        • indication
          • in patients with asymptomatic chondrocalcinosis
    • Medical
      • nonsteroidal anti-inflammatory drugs (NSAIDs)
        • indication
          • an initial treatment option for pseudogout
      • colchicine
        • indication
          • an initial treatment option for pseudogout
      • glucocorticoids
        • indications
          • injections of the affected joint is typically used in patients with < 2 involved joints
          • oral medications are typically used in patients with > 2 involved joints
  • Complications
    • Joint damage
1 of 0
1 of 2
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options